Minervax in a €22 million equity round backed by Trill Impact Ventures and Pureos Bioventures
10 December 2022
10 December 2022
Total investments received (USD): 166.09M
Round value (USD): 23.39M
Company: MinervaX
Industry: BiotechHealth services
Related deals
Bactolife raised €30m Series B led by Cross Border Impact Ventures and EIFO, joined by Novo Holdings, family office Athos and the Gates Foundation
Investments
27 December 2025
Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain